ba0003pp101 | Cancer and bone: basic, translational and clinical | ECTS2014
Amrein Karin
, Drexler Camilla
, Oczko Susanna
, Sareban Nazanin
, Sipurzynski Sabine
, Pieber Thomas R.
, Lanzer Gerhard
, Wagner Doris
, Fahrleitner-Pammer Astrid
Introduction: Granulocyte colony-stimulating factor (G-CSF) is widely used to mobilize peripheral blood stem cells (PBSC) and enable PBSC collection by apheresis. Although bone pain is a common adverse event following G-CSF treatment, little is known on its effect on bone metabolism.Methods: Markers of bone turnover (OC, osteocalcin, β-CTx, bALP, C-terminal telopeptide of type I collagen, bone specific alkaline phosphatase, TRAP, tartrate resistant ...